Literature DB >> 16293639

Activation of the lutropin/choriogonadotropin receptor in MA-10 cells leads to the tyrosine phosphorylation of the focal adhesion kinase by a pathway that involves Src family kinases.

Tetsuya Mizutani1, Koji Shiraishi, Toni Welsh, Mario Ascoli.   

Abstract

We show that activation of the endogenous or recombinant lutropin/choriogonadotropin receptor (LHR) in mouse Leydig tumor cells (MA-10 cells) leads to the tyrosine phosphorylation of the focal adhesion kinase (FAK) and one of its substrates (paxillin). Using specific antibodies to the five tyrosine residues of FAK that become phosphorylated, we show that activation of the LHR increases the phosphorylation of Tyr576 and Tyr577, but it does not affect the phosphorylation of Tyr397, Tyr861, or Tyr925. Because FAK is a prominent substrate for the Src family of tyrosine kinases (SFKs) we tested for their involvement in the LHR-mediated phosphorylation of FAK-Tyr576. Src is not detectable in MA-10 cells, but two other prominent members of this family (Fyn and Yes) are present. The LHR-mediated phosphorylation of FAK-Tyr576 is readily inhibited by PP2 (a pharmacological inhibitor of SFKs) and by dominant-negative mutants of SKFs. Moreover, activation of the LHR in MA-10 cells results in the stimulation of the activity of Fyn and Yes, and overexpression of either of these two tyrosine kinases enhances the LHR-mediated phosphorylation of FAK-Tyr576. Studies involving activation of other G protein-coupled receptors, overexpression of the different Galpha-subunits, and the use of second messenger analogs suggest that the LHR-induced phosphorylation of FAK-Tyr576 in MA-10 cells is mediated by SFKs, and that this family of kinases is, in turn, independently or cooperatively activated by the LHR-induced stimulation of Gs and Gq/11-mediated pathways.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16293639      PMCID: PMC1382007          DOI: 10.1210/me.2005-0277

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  43 in total

1.  Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor.

Authors:  G Liu; L Duranteau; J C Carel; J Monroe; D A Doyle; A Shenker
Journal:  N Engl J Med       Date:  1999-12-02       Impact factor: 91.245

Review 2.  Endothelin system: the double-edged sword in health and disease.

Authors:  R M Kedzierski; M Yanagisawa
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

Review 3.  Naturally occurring mutations of the luteinizing-hormone receptor: lessons learned about reproductive physiology and G protein-coupled receptors.

Authors:  A C Latronico; D L Segaloff
Journal:  Am J Hum Genet       Date:  1999-10       Impact factor: 11.025

Review 4.  Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function.

Authors:  I T Huhtaniemi
Journal:  Endocr Rev       Date:  2000-10       Impact factor: 19.871

5.  Yes-associated protein and p53-binding protein-2 interact through their WW and SH3 domains.

Authors:  X Espanel; M Sudol
Journal:  J Biol Chem       Date:  2001-01-31       Impact factor: 5.157

6.  c-Src tyrosine kinase binds the beta 2-adrenergic receptor via phospho-Tyr-350, phosphorylates G-protein-linked receptor kinase 2, and mediates agonist-induced receptor desensitization.

Authors:  G Fan ; E Shumay; C C Malbon; H Wang
Journal:  J Biol Chem       Date:  2001-01-22       Impact factor: 5.157

Review 7.  Selected glimpses into the activation and function of Src kinase.

Authors:  J D Bjorge; A Jakymiw; D J Fujita
Journal:  Oncogene       Date:  2000-11-20       Impact factor: 9.867

8.  Src tyrosine kinase is a novel direct effector of G proteins.

Authors:  Y C Ma; J Huang; S Ali; W Lowry; X Y Huang
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

Review 9.  The hunting of the Src.

Authors:  G S Martin
Journal:  Nat Rev Mol Cell Biol       Date:  2001-06       Impact factor: 94.444

Review 10.  The role of focal-adhesion kinase in cancer - a new therapeutic opportunity.

Authors:  Gordon W McLean; Neil O Carragher; Egle Avizienyte; Jeff Evans; Valerie G Brunton; Margaret C Frame
Journal:  Nat Rev Cancer       Date:  2005-07       Impact factor: 60.716

View more
  14 in total

1.  Notch signaling represses GATA4-induced expression of genes involved in steroid biosynthesis.

Authors:  Rajani M George; Katherine L Hahn; Alan Rawls; Robert S Viger; Jeanne Wilson-Rawls
Journal:  Reproduction       Date:  2015-07-16       Impact factor: 3.906

2.  Reactive oxygen species (ROS) play a critical role in the cAMP-induced activation of Ras and the phosphorylation of ERK1/2 in Leydig cells.

Authors:  Ping Tai; Mario Ascoli
Journal:  Mol Endocrinol       Date:  2011-02-17

3.  FYN is overexpressed in human prostate cancer.

Authors:  Edwin M Posadas; Hikmat Al-Ahmadie; Victoria L Robinson; Ramasamy Jagadeeswaran; Kristen Otto; Kristen E Kasza; Maria Tretiakov; Javed Siddiqui; Kenneth J Pienta; Walter M Stadler; Carrie Rinker-Schaeffer; Ravi Salgia
Journal:  BJU Int       Date:  2008-10-16       Impact factor: 5.588

4.  Dax-1 and steroid receptor RNA activator (SRA) function as transcriptional coactivators for steroidogenic factor 1 in steroidogenesis.

Authors:  Bin Xu; Wei-Hsiung Yang; Isabelle Gerin; Chang-Deng Hu; Gary D Hammer; Ronald J Koenig
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

5.  Activation of the lutropin/choriogonadotropin receptor inhibits apoptosis of immature Leydig cells in primary culture.

Authors:  Ping Tai; Koji Shiraishi; Mario Ascoli
Journal:  Endocrinology       Date:  2009-04-30       Impact factor: 4.736

6.  A co-culture system reveals the involvement of intercellular pathways as mediators of the lutropin receptor (LHR)-stimulated ERK1/2 phosphorylation in Leydig cells.

Authors:  Koji Shiraishi; Mario Ascoli
Journal:  Exp Cell Res       Date:  2007-07-17       Impact factor: 3.905

7.  Mutations of the lutropin/choriogonadotropin receptor that do not activate the phosphoinositide cascade allow hCG to induce aromatase expression in immature rat granulosa cells.

Authors:  Nebojsa Andric; Mario Ascoli
Journal:  Mol Cell Endocrinol       Date:  2008-02-03       Impact factor: 4.102

8.  The luteinizing hormone receptor-activated extracellularly regulated kinase-1/2 cascade stimulates epiregulin release from granulosa cells.

Authors:  Nebojsa Andric; Mario Ascoli
Journal:  Endocrinology       Date:  2008-07-24       Impact factor: 4.736

9.  Arrestin-3 is essential for the activation of Fyn by the luteinizing hormone receptor (LHR) in MA-10 cells.

Authors:  Colette Galet; Mario Ascoli
Journal:  Cell Signal       Date:  2008-06-19       Impact factor: 4.315

10.  Lutropin/choriogonadotropin stimulate the proliferation of primary cultures of rat Leydig cells through a pathway that involves activation of the extracellularly regulated kinase 1/2 cascade.

Authors:  Koji Shiraishi; Mario Ascoli
Journal:  Endocrinology       Date:  2007-04-05       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.